Table of Content - Vernal Keratoconjunctivitis Market

The inner surface of the eyelid is lined with conjunctiva, a translucent tissue layer. When infected, this tissue tends to cover the white area of the eye and turn red or pink. As a result, the eye ailment conjunctivitis is often known as pink eye. The infection of the eye known as conjunctivitis is a common symptom of this ophthalmic condition. Infectious causes includes bacterial and viral infections, while non-infectious causes include allergy and immune-mediated illness inflammation. It is categorised into acute conjunctivitis, super acute conjunctivitis, and chronic conjunctivitis.

Vernal keratoconjunctivitis (VKC) is a chronic, multifactorial Th2-cell-mediated inflammatory disease of the ocular surface. It is distinguished by a large papilla on the upper tarsal conjunctiva and a corneoscleral junction. Hyperemia and mucus discharge are typical symptoms of VKC. There is no set standard treatment strategy for VKC. Mast cell stabilisers, antihistamines, nonsteroidal anti-inflammatory medications (NSAIDs), topical corticosteroids, and cyclosporine are available as treatments. Individuals receiving treatment should be continuously observed for the development of any ocular problems.

Market Dynamics

Increasing R&D activities in vernal keratoconjunctivitis for a better understanding of the disease is expected to drive the growth of global vernal keratoconjunctivitis market during the forecast period. In addition, increasing prevalence of vernal keratoconjuctivitis and supportive therapies have built the interest in several pharmaceutical companies in developing a cure for the disease. A greater knowledge of the disease's biology and manifestation of the disease has boosted efforts to develop improved treatment alternatives in the form of pipeline treatments, which is projected to propel the global vernal keratoconjunctivitis market share during the forecast period.

Key features of the study

This report provides an in-depth analysis of the global vernal keratoconjunctivitis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vernal keratoconjunctivitis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Santen, Novartis Pharmaceuticals, Senju Pharmaceutical, Allakos, iCo Therapeutics, and Akari Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vernal keratoconjunctivitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global vernal keratoconjunctivitis market

Market Segmentation

By Drug Type (Revenue, USD Mn, 2021-2033)
- Bertilimumab
- Verkazia
- Lodoxamide
- Tacrolimus
- Antolimab
- Nomacopan
- Others
By Treatment (Revenue, USD Mn, 2021-2033)
- Mast Cell Stabilizers
- Antihistamines
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Topical Corticosteroids
- Cyclosporine
- Tacrolimus
- Others
By Dosage Form (Revenue, USD Mn, 2021-2033)
- Gel
- Ointment
- Tablet
- Others
By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region (Revenue, USD Mn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Santen
- Novartis Pharmaceuticals
- Senju Pharmaceutical
- Allakos
- iCo Therapeutics
- Akari Therapeutics

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Treatment
  - Market Snapshot, By Dosage Form
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global Vernal Keratoconjunctivitis Market, By Drug Type, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Bertilimumab
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Verkazia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Lodoxamide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Tacrolimus
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Antolimab
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Nomacopan
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
Global Vernal Keratoconjunctivitis Market, By Treatment, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Mast Cell Stabilizers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Antihistamines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Topical Corticosteroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Cyclosporine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Tacrolimus
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
Global Vernal Keratoconjunctivitis Market, By Dosage Form, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Gel
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Ointment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Tablet
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
Global Vernal Keratoconjunctivitis Market, By Distribution Channel, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Retail Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Online Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
Global Vernal Keratoconjunctivitis Market, By Region, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Santen
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Novartis Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Senju Pharmaceutical
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Allakos
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - iCo Therapeutics
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Akari Therapeutics
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE